Sebastian Markmiller

Sebastian Markmiller

Auto-generated profile, based on publicly available information

Sebastian Markmiller

Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA 92093, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA 92093, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Cell
Verified
Journal Article
Closed access
SMSebastian Markmiller
Sebastian Markmiller
SSSahar Soltanieh
Sahar Soltanieh
KSKari L. Server
Kari L. Server
RMRaymond Mak
Raymond Mak
WJWenhao Jin
Wenhao Jin
GYGene W. Yeo
Gene W. Yeo

1 September 2019 in Neuron
Verified
Journal Article
Closed access
MFMark Y. Fang
Mark Y. Fang
SMSebastian Markmiller
Sebastian Markmiller
AVAnthony Q. Vu
Anthony Q. Vu
AJAshkan Javaherian
Ashkan Javaherian
WDWilliam E. Dowdle
William E. Dowdle
GYGene W. Yeo
Gene W. Yeo

10 February 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SMSebastian Markmiller
Sebastian Markmiller
NCNicole Cloonan
Nicole Cloonan
RLRea M. Lardelli
Rea M. Lardelli
KDKaren Doggett
Karen Doggett
MKMaria-Cristina Keightley
Maria-Cristina Keightley
JHJoan K. Heath
Joan K. Heath
Minor class or U12-type splicing is a highly conserved process required to remove a minute fraction of introns from human pre-mRNAs. Defects in this splicing pathway have recently been linked to human disease, including a severe developmental disorder encompassing brain and skeletal abnormalities known as Taybi-Linder syndrome or microcephalic osteodysplastic primordial dwarfism 1, and a hereditary intestinal polyposis condition, Peutz-Jeghers syndrome. Although a key mechanism for regulating gene expression, the impact of impaired U12-type splicing on the transcriptome is unknown. Here, we describe a unique zebrafish mutant, caliban (clbn), with arrested development of the digestive organs caused by an ethylnitrosourea-induced recessive lethal point mutation in the rnpc3 [RNA-binding region (RNP1, RRM) containing 3] gene. rnpc3 encodes the zebrafish ortholog of human RNPC3, also known as the U11/U12 di-snRNP 65-kDa protein, a unique component of the U12-type spliceosome. The biochemical impact of the mutation in clbn is the formation of aberrant U11- and U12-containing small nuclear ribonucleoproteins that impair the efficiency of U12-type splicing. Using RNA sequencing and microarrays, we show that multiple genes involved in various steps of mRNA processing, including transcription, splicing, and nuclear export are disrupted in clbn, either through intron retention or differential gene expression. Thus, clbn provides a useful and specific model of aberrant U12-type splicing in vivo. Analysis of its transcriptome reveals efficient mRNA processing as a critical process for the growth and proliferation of cells during vertebrate development. Significance The accurate removal of introns by pre-mRNA splicing is a critical step in proper gene expression. Most eukaryotic genomes, from plant to human, contain a tiny subset of “minor class” introns with unique sequence elements that require their own splicing machinery. The significance of this second splicing pathway has intrigued RNA biologists for two decades, but its biological relevance was recently underscored when defects in the process were firmly linked to human disease. Here, we use a novel zebrafish mutant with defective minor class splicing to investigate how this pathway shapes the transcriptome during vertebrate development. We link its pleiotropic phenotype to widespread changes in gene expression that disrupt essential cellular pathways, including mRNA processing.

15 June 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
ISIsabella I. Sanchez
Isabella I. Sanchez
TNThai B. Nguyen
Thai B. Nguyen
WEWhitney E. England
Whitney E. England
RLRyan G. Lim
Ryan G. Lim
AVAnthony Q. Vu
Anthony Q. Vu
LTLeslie M. Thompson
Leslie M. Thompson
Chronic cellular stress associated with neurodegenerative disease can result in the persistence of stress granule (SG) structures, membraneless organelles that form in response to cellular stress. In Huntington’s disease (HD), chronic expression of mutant huntingtin generates various forms of cellular stress, including activation of the unfolded protein response and oxidative stress. However, it has yet to be determined whether SGs are a feature of HD neuropathology. We examined the miRNA composition of extracellular vesicles (EVs) present in the cerebrospinal fluid (CSF) of patients with HD and show that a subset of their target mRNAs were differentially expressed in the prefrontal cortex. Of these targets, SG components were enriched, including the SG-nucleating Ras GTPase-activating protein-binding protein 1 (G3BP1). We investigated localization and levels of G3BP1 and found a significant increase in the density of G3BP1-positive granules in the cortex and hippocampus of R6/2 transgenic mice and in the superior frontal cortex of the brains of patients with HD. Intriguingly, we also observed that the SG-associated TAR DNA-binding protein 43 (TDP43), a nuclear RNA/DNA binding protein, was mislocalized to the cytoplasm of G3BP1 granule–positive HD cortical neurons. These findings suggest that G3BP1 SG dynamics may play a role in the pathophysiology of HD.

1 April 2019 in Cell Reports
Verified
Journal Article
Open access
SMSebastian Markmiller
Sebastian Markmiller
AFAmit Fulzele
Amit Fulzele
RHReneé Higgins
Reneé Higgins
MLMarilyn Leonard
Marilyn Leonard
GYGene W. Yeo
Gene W. Yeo
EBEric J. Bennett
Eric J. Bennett
Stress granule (SG) formation is frequently accompanied by ubiquitin proteasome system (UPS) impairment and ubiquitylated protein accumulation. SGs, ubiquitin, and UPS components co-localize, but the relationship between the ubiquitin pathway and SGs has not been systematically characterized. We utilize pharmacological inhibition of either the ubiquitin- or NEDD8-activating enzyme (UAE or NAE) to probe whether active ubiquitylation or neddylation modulate SG dynamics. We show that UAE inhibition results in rapid loss of global protein ubiquitylation using ubiquitin-specific proteomics. Critically, inhibiting neither UAE nor NAE significantly affected SG formation or disassembly, indicating that active protein ubiquitylation or neddylation is dispensable for SG dynamics. Using antibodies with varying preference for free ubiquitin or polyubiquitin and fluorescently tagged ubiquitin variants in combination with UAE inhibition, we show that SGs co-localize primarily with unconjugated ubiquitin rather than polyubiquitylated proteins. These findings clarify the role of ubiquitin in SG biology and suggest that free ubiquitin may alter SG protein interactions.

1 January 2016
Verified
Book Chapter
Closed access
MKMaria-Cristina Keightley
Maria-Cristina Keightley
SMS. Markmiller
S. Markmiller
CLC.G. Love
C.G. Love
JRJohn E.J. Rasko
John E.J. Rasko
GLGraham Lieschke
Graham Lieschke
JHJ.K. Heath
J.K. Heath